Endometrial cancer laboratory findings: Difference between revisions

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer laboratory findings On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer laboratory findings
CDC on Endometrial cancer laboratory findings
Endometrial cancer laboratory findings in the news
Blogs on Endometrial cancer laboratory findings
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer laboratory findings

Revision as of 14:24, 29 November 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

There are no diagnostic laboratory findings associated with endometrial cancer.

@@ Line 4: / Line 4: @@
 ==Overview==
-The laboratory findings associated with endometrial carcinoma are the following: CBC, serum [[CA-125]] concentration, liver function tests, and pulmonary function tests.
+There are no diagnostic laboratory findings associated with endometrial cancer.
 ==Endometrial Cancer Laboratory Findings==
-* Complete blood count and differential count,[[anemia]]
+* There are no diagnostic laboratory findings associated with endometrial cancer.
-* Serum '''[[CA-125]]''' -The tumor marker is checked, since this can predict advanced stage disease.<ref>Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34. PMID 10871446.</ref>
+* Measurement of CBC is only necessary if heavy uterine bleeding is present.
-* Hypercalcemia may be present due to metastasis to the bone
-* Abnormal [[liver function tests]] may be present due to  metastasis to the liver
-* Abnormal [[pulmonary function tests]]may be present due to metastasis to the lung
 ==References==